castlecreekpharma.com
Castle Creek Pharma Announces $71.8 Million in New Investment to Expand Research for Rare Dermatologic Conditions
Castle Creek Pharma secures new investment from Fidelity Management & Research Company and Valor Equity Partners towards the late stage development of Diacerein Ointment for the treatment of Epidermolysis Bullosa Simplex PARSIPPANY, NJ – October 19, 2018 – Castle Creek Pharma (Castle Creek), a US-based company which develops therapies for orphan dermatologic and